Evolent Health (EVH) Preferred Stock Liabilities (2013 - 2025)

Evolent Health's Preferred Stock Liabilities history runs 5 years deep, the most recent figure standing at $228.8 million for Q2 2025.

• In Q2 2025, Preferred Stock Liabilities rose 24.21% year-over-year to $228.8 million; the TTM figure through Jun 2025 stood at $228.8 million (up 24.21% YoY), while the FY2024 annual figure was $190.2 million, up 6.58% from the prior year.
• Preferred Stock Liabilities was $228.8 million for Q2 2025 at Evolent Health, up from $193.2 million in the prior quarter.
• In the past five years, Preferred Stock Liabilities ranged from a high of $228.8 million in Q2 2025 to a low of $170.6 million in Q1 2023.
• Historically, Preferred Stock Liabilities has averaged $186.2 million across 3 years, with a median of $182.8 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Preferred Stock Liabilities increased 6.25% in 2024, then advanced 24.21% in 2025.
• A 3-year view of Preferred Stock Liabilities shows it stood at $178.4 million in 2023, then rose by 6.58% to $190.2 million in 2024, then advanced by 20.31% to $228.8 million in 2025.
• The last three Preferred Stock Liabilities figures came in at $228.8 million (Q2 2025), $193.2 million (Q1 2025), and $190.2 million (Q4 2024), per Business Quant data.